報價延遲最少15分鐘:2025/03/28 08:24 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.54 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.28/0.06
|
|
企業價值
42.47M
|
| 資產負債 |
|
每股賬面淨值
8.46
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
48.73M
|
|
每股收益
6.82
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/03/28 08:24 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods. |